
Pharmacelera and eMolecules Launch Integrated Solution for Faster Hit Discovery
California, US & Barcelona, Spain — October 13th, 2025 — Together with eMolecules we announce the launch of a new integrated solution combining ExaScreen® with
California, US & Barcelona, Spain — October 13th, 2025 — Together with eMolecules we announce the launch of a new integrated solution combining ExaScreen® with
Cambridge, UK & Barcelona, Spain — August 27th, 2025 — Domainex, a leading integrated drug discovery services company, and Pharmacelera, a pioneer
We are thrilled to announce a collaboration between Pharmacelera and the UMass Chan Medical School aimed to support early-stage drug discovery projects.
By Nicola Scafuri and Ana Caballero A larger number of ligands in the virtual screening library increases the chances of identifying ligands
By Carlos Cruz and Ana Caballero The success of a ligand-based virtual screening campaign relies on their molecular descriptors, in this sense,
By Tiziana Ginex and Fernando Martin The ever-increasing accessible chemical space opens the door to the search for new chemical matter for
Commercial chemical libraries have witnessed remarkable growth in recent years, resulting in an unprecedented increase in size and diversity. With advancements in
3D quantum-mechanics, molecular descriptors, and artificial intelligence provide unique capabilities in the chemical space to identify and qualify novel hits PALO ALTO,